Research and Development

Janssen biotech has signed a licensing deal with Pharmacyclics for its investigational blood cancer drug. The firm has paid $150 …

Dechra® Pharmaceuticals PLCFDA APPROVAL FOR MANUFACTURING AT DALES® PHARMACEUTICALS  Dales Pharmaceuticals (‘Dales’ or the ‘Company’), based in Skipton, North Yorkshire, UK, …

Takeda will establish a new vaccine business division in January next year and will appoint Dr Rajeev Venkayya as its …

Roche’s next generation breast cancer drug pertuzumab has helped patients to live over six months longer. CLEOPATRA, the first randomised …

AstraZeneca will cut around 1,150 positions in the US as large patent expiries loom. The cuts will come primarily from …

Deepak Khanna, senior vice president and UK managing director of Merck, Sharp and Dohme has been named as president-elect of …

Merck is moving further into China by establishing its new Asian research and development headquarters in Beijing.  The Wangjing Park …

The European Cosmetics Directive has been recast and the new legislation takes the form of Regulation 1223/2009.  As a Regulation, …

Roche has unveiled a new research collaboration with academic researchers and leading clinical centres in Switzerland. The Basel-based pharma company …

John LaMattina joined Pfizer in 1977 after having completed his PhD in organic chemistry, and moved up through the ranks …

AstraZeneca will make 22 of its compounds available free of charge to UK academia next year as part of a …

A new test which should help to better target treatment of patients with non-small cell lung cancer (NSCLC) has received …

The government has unveiled plans to help support the UK’s life science industries.The new package of measures includes £180 million …

The European Commission has created a new €80 billion budget in an effort to encourage research and innovation across the …

Merck KGaA has appointed Dr Friederike Rotsch as its new head of corporate auditing. She reports to Karl-Ludwig Kley, chairman …